NASHVILLE, Tenn. / Aug 12, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present at the following healthcare conferences:
September 5, 2024 at 8:00am ET at the 2024 Wells Fargo Healthcare Conference at the Encore Boston Arbor in Everett, MA.
September 5, 2024 at 3:20pm ET at Morgan Stanley’s 22nd Annual Global Healthcare Conference at the Marriott Marquis in New York, NY.
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.
Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 188 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom.
All references to “Company” and “HCA” as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.
| Last Trade: | US$419.08 |
| Daily Change: | 4.19 1.01 |
| Daily Volume: | 1,146,061 |
| Market Cap: | US$98.060B |
August 27, 2025 July 25, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
